Study: Diabetes Pill Prevents Type 2 in 72 Percent of Participants
March 25, 2011 9:15 AM
In addition, 31 percent experienced a reduced rate of thickening of the carotid artery, which is a vessel that supplies blood to the brain
Researchers from the
University of Texas Health Science Center at San Antonio
and seven other collaborating centers have led a trial that demonstrates a pill that prevents type 2 diabetes in those high at risk.
Ralph DeFronzo, M.D., study leader and professor in the School of Medicine and chief of the diabetes division at the University of Texas Health Science Center in San Antonio, along with Robert Henry, M.D., president of the American Diabetes Association, have conducted a trial to show a pill that is capable of
preventing type 2 diabetes
in people who are high at risk due to
or their ethnicity and other markers. Type 2 diabetes is caused by abnormalities associated with insulin, which is secreted by beta cells in the pancreas. The body is insulin resistant when type 2 diabetes is present, meaning that the body is unable to store and use sugar from food and beta cells begin to die as time goes by. Currently, 40 million Americans are pre-diabetic.
The pill is called pioglitazone, and it is marketed as Actos® by Takeda Pharmaceutical Co. Ltd., which gave DeFronzo an independent investigator grant in order to conduct the study. Pioglitazone is an insulin sensitizer for those with type 2 diabetes, which works by stimulating appetite and shifting fat from from the liver, muscles, and beta cells into subcutaneous "fat depots" under the skin where it is not harmful.
The study, which was called
the ACT Now study
, consisted of 602 test subjects that had a high risk of developing type 2 diabetes. They were instructed to take the pill once a day in the morning.
According to results, 72 percent of participants benefitted from the pill and did not develop type 2 diabetes. In addition, 31 percent experienced a reduced rate of thickening of the carotid artery, which is a vessel that supplies blood to the brain.
"It's a blockbuster study," said DeFronzo. "The 72 reduction is the largest decrease in the conversion rate of pre-diabetes to diabetes that has ever been demonstrated by any intervention, be it diet, exercise or medication."
According to Robert Chilton, D.O., FACC, a University of Texas Health Science Center San Antonio cardiologist, the pill controlled participants' glucose and prevented blood vessel damage that can cause
The side effects of pioglitazone are weight gain and fluid retention, but DeFronzo said these can be avoided by taking lower doses. He has admitted that the drug hasn't been perfected quite yet, but it improves insulin resistance and beta cell function, which makes the pill an excellent first step to treating and preventing diabetes successfully.
"The drug shows outstanding results," said Henry. "It is the most efficacious method we have studied to date to delay or prevent the onset of type 2 diabetes."
was published in
The New England Journal of Medicine
"This is about the Internet. Everything on the Internet is encrypted. This is not a BlackBerry-only issue. If they can't deal with the Internet, they should shut it off." -- RIM co-CEO Michael Lazaridis
Growth Hormone Deficiency May Prevent Diabetes, Cancer
February 18, 2011, 6:24 AM
World Has Grown Much, Much Fatter: Obesity Doubles in 30 Years
February 4, 2011, 11:03 AM
New Microthread Technology Could Deliver Stem Cells Directly to Damaged Hearts
December 10, 2010, 9:45 AM
Birth Control Contributes to Depression in Teens and Young Women
October 26, 2016, 4:31 AM
Cyber Hackers Threaten Security of Lifesaving Medical Devices
October 19, 2016, 8:09 AM
Innovative Neurotechnology in Sound Therapy Reduces High Blood Pressure and Migraines
October 16, 2016, 5:00 AM
Researchers Move Closer to Breakthrough Gene Therapy to Cure Sickle Cell
October 14, 2016, 5:00 AM
Keytruda: A breakthrough treatment to increase survival rates for lung cancer patients
October 12, 2016, 5:00 AM
CDC Warning about Record High Increases in 2016 for Polio-like Illness causing Paralysis
October 9, 2016, 5:00 AM
Most Popular Articles
Car Insurance - The Hidden Discriminatory Practise
October 18, 2016, 5:00 AM
Tesla Announces Level 5 Autonomous Driving
October 19, 2016, 8:30 PM
Apple iOS Contains Secret One-handed Keyboard Code
October 22, 2016, 5:00 AM
Thieves Love iPhones – More than $13,000 Stolen from Apple Store
October 21, 2016, 7:13 AM
Do you hate to do yard work?
October 20, 2016, 5:00 AM
Latest Blog Posts
Key EpiPen Competitor Out in 2017 At ' Very Low' Cost
Oct 27, 2016, 5:30 AM
Researchers use CRISPR to Accelerate Search for HIV Cure
Oct 26, 2016, 5:00 AM
Medical Council of India Makes Generic Medicines Mandatory
Oct 25, 2016, 5:00 AM
MacBoo Pro 2016: Release date Oct. 27
Oct 24, 2016, 7:16 AM
Mac Users, Try this if Your Mac is Infected?
Oct 23, 2016, 7:00 AM
Tips to Prevent Smartphones From Overheating:
Oct 22, 2016, 5:00 AM
Nasa Flies Drones at Nevada Airport
Oct 21, 2016, 8:21 AM
T-Mobile Data Problems
Oct 20, 2016, 10:17 AM
Annoying Apple Watch Problems and How to Fix Them
Oct 20, 2016, 5:00 AM
Your Mail May Soon Be Delivered By Robot
Oct 19, 2016, 9:34 AM
2018 Jeep Wrangler Prototype Sells At Junkyard
Oct 18, 2016, 5:00 AM
Samsung Shines with Gold Edition Tablet
Oct 17, 2016, 9:24 AM
Tesla Hints Mysterious Product Debut for October 17th
Oct 16, 2016, 10:14 AM
Samsung Galaxy Note 7 Phones on US flights
Oct 15, 2016, 5:00 AM
Comcast Fined $2.3 Million For Unconfirmed Services Charged To Customers
Oct 14, 2016, 5:00 AM
“American singer / songwriter “Bob Dylan is awarded 2016 Nobel Prize in Literature.
Oct 13, 2016, 10:33 AM
Battery Defect in Medical Device
Oct 12, 2016, 5:00 AM
More Blog Posts
Copyright 2016 DailyTech LLC. -
Terms, Conditions & Privacy Information